Skip to main content

Advertisement

Fig. 1 | BMC Cancer

Fig. 1

From: Favorable prognosis in colorectal cancer patients with co-expression of c-MYC and ß-catenin

Fig. 1

Representative figures of c-MYC status detected by in situ hybridization (a and d) and immunohistochemistry (IHC; b and e), and of ß-catenin expression by IHC (c and f), in colorectal cancer patients. a Score 4 mRNA (40×); b c-MYC overexpression (40×); c Nuclear ß-catenin expression (40×); d Score 0 mRNA (40×); e No c-MYC expression (40×); f Membranous ß-catenin expression (40×)

Back to article page